Borm, A. K., Klevesath, M., Borcea, V., Kasperk, C., Seibel, M. J., Wahl, P., . . . Nawroth, P. P. (1999). The effect of pramlintide (amylin analogue) treatment on bone metabolism and bone density in patients with type 1 diabetes mellitus. Hormone and metabolic research, 31(8), . https://doi.org/10.1055/s-2007-978777
Chicago Style (17th ed.) CitationBorm, Anne Katrin, Martina Klevesath, Valentin Borcea, Christian Kasperk, Markus J. Seibel, Peter Wahl, Reinhard Ziegler, and Peter Paul Nawroth. "The Effect of Pramlintide (amylin Analogue) Treatment on Bone Metabolism and Bone Density in Patients with Type 1 Diabetes Mellitus." Hormone and Metabolic Research 31, no. 8 (1999). https://doi.org/10.1055/s-2007-978777.
MLA (9th ed.) CitationBorm, Anne Katrin, et al. "The Effect of Pramlintide (amylin Analogue) Treatment on Bone Metabolism and Bone Density in Patients with Type 1 Diabetes Mellitus." Hormone and Metabolic Research, vol. 31, no. 8, 1999, https://doi.org/10.1055/s-2007-978777.